ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Wolters Kluwer Gives Medical Researchers a Productivity Boost with Ovid AI Article Summary

AI summarization enhances medical research workflows with instant, trustworthy synopses to help streamline information gathering

Wolters Kluwer Health today announced the addition of AI Article Summary to the Ovid platform—helping researchers save time by quickly distilling insights from peer-reviewed literature earlier in their discovery process. The feature is currently available in Beta on a selection of LWW proprietary journals within the Ovid platform. Generative artificial intelligence (AI) provides concise summaries of articles, enhancing the research experience for healthcare professionals, researchers, and students.

“Amid the accelerating pace of research publishing, and while balancing patient care, administrative demands, and teaching, clinicians and researchers need support in identifying relevant insights faster,” said Rafael Sidi, Senior Vice President & General Manager of Health Research, Wolters Kluwer Health. “The concise, plain-language snapshot provided with Ovid’s AI Article Summary feature helps users quickly evaluate and understand articles with confidence.”

AI summarization built for researchers, by researchers

Having AI article summarization built right into the Ovid platform saves users valuable time by helping them quickly identify the key points of lengthy research papers. This is particularly relevant for contemporary clinical care and research. The immense volume of new research published every day makes manual curation and distillation a formidable task. Not only is the summarizer helpful for quickly sharing insights with colleagues, but it also helps busy clinicians and researchers to stay current with the latest evidence.

Ovid’s AI Article Summary tool highlights tactical and ready-to-use insights, as well as key, salient points most relevant to clinical decision-making. This distinction means users receive practical, applicable information quicker. Additionally, the AI generated summaries in Ovid are consistent in structure regardless of journal, making it easier for researchers to quickly distill information from different sources.

Meeting the demands of modern healthcare

“Ovid’s AI Article Summary translates intricate research into clear and actionable insights, enabling evidence-based practices in real-world settings. This is a key step in translating the rapid rate of scientific and research progress to improvements in clinical care delivery,” added Thomas C. Kingsley MD, MPH, MS, Assistant Professor of Medicine David Geffen School of Medicine UCLA.

Ovid’s integrated summarization feature offers a research-centric, user-informed design that has direct alignment with clinician and researcher workflows, pinpointing critical findings and methodological insights without ever leaving Ovid. This unique capability was built leveraging specialized prompt engineering to extract clinically and scientifically pertinent information effectively and reliably.

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.